Jin Medical International Ltd.
ZJYL
$0.6407
-$0.0019-0.30%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.29% | 35.29% | 2.96% | 2.96% | -1.59% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.29% | 35.29% | 2.96% | 2.96% | -1.59% |
| Cost of Revenue | 14.37% | 14.37% | 2.10% | 2.10% | -5.18% |
| Gross Profit | 74.44% | 74.44% | 4.53% | 4.53% | 5.91% |
| SG&A Expenses | 98.14% | 98.14% | 68.15% | 68.15% | 30.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -40.92% | -40.92% | -40.08% | -40.08% | -2.49% |
| Total Operating Expenses | 24.35% | 24.35% | 9.97% | 9.97% | -1.59% |
| Operating Income | 119.89% | 119.89% | -30.61% | -30.61% | -1.63% |
| Income Before Tax | 73.41% | 73.41% | 2.18% | 2.18% | -14.65% |
| Income Tax Expenses | 225.79% | 225.79% | 51.47% | 51.47% | 1,083.10% |
| Earnings from Continuing Operations | 54.29% | 54.29% | -3.51% | -3.51% | -24.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 69.26% | 69.26% | 1.56% | 1.56% | -24.91% |
| EBIT | 119.89% | 119.89% | -30.61% | -30.61% | -1.63% |
| EBITDA | 109.34% | 109.34% | -28.46% | -28.46% | -9.29% |
| EPS Basic | 66.67% | 66.67% | -12.31% | -12.31% | -34.55% |
| Normalized Basic EPS | 96.00% | 96.00% | -6.52% | -6.52% | -28.57% |
| EPS Diluted | 66.67% | 66.67% | -12.31% | -12.31% | -34.55% |
| Normalized Diluted EPS | 96.00% | 96.00% | -6.52% | -6.52% | -28.57% |
| Average Basic Shares Outstanding | 0.96% | 0.96% | 15.66% | 15.66% | 14.85% |
| Average Diluted Shares Outstanding | 0.96% | 0.96% | 15.66% | 15.66% | 14.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |